Keck Medicine of USC Launches Clinical Trial to Study Anti-Inflammatory Drug as Treatment for COVID-19
May 6, 2020 Keck Medicine of USC physicians are launching a clinical trial to evaluate the efficacy and safety of baricitinib, an anti-inflammatory drug approved by the Food and Drug
May 4, 2020 Keck Medicine of USC will begin resuming a limited number of medically necessary, time-sensitive surgeries and outpatient procedures at Keck Medical Center of USC, USC Verdugo Hills Hospital
For asthma patients, the novel coronavirus can be scary. The new coronavirus' ability to wreak havoc in the lungs is raising a lot of concerns and questions from my asthma patients.
The comprehensive program, launched by Keck Medicine of USC and USC, offers housing, mental health support and comfort amenities to high-risk health care workers. Keck Medicine and USC have launched